Delek US (DK) Director Yemin Ezra Uzi Sells $13.5M Shares

What Happened
Yemin Ezra Uzi, a director of Delek US Holdings, sold a total of 200,000 shares in open‑market transactions on August 13, 2026. The sales were reported in four blocks: 17,566 shares at $65.75 ($1,154,965); 38,388 shares at $66.64 ($2,558,176); 82,224 shares at $67.74 ($5,569,854); and 61,822 shares at $68.27 ($4,220,588). Total proceeds across all reported sales were $13,503,583. These were outright sales (dispositions), not purchases.

Key Details

• Transaction date: 2026-08-13; Form 4 filed 2026-08-17 (timely within two business days). Accession: 0001361091-26-000019.
• Reported blocks and amounts:
  • 17,566 shares @ $65.75 = $1,154,965 (F2 notes weighted avg of $65.15–$66.13)
  • 38,388 shares @ $66.64 = $2,558,176 (F3 notes weighted avg of $66.15–$67.13)
  • 82,224 shares @ $67.74 = $5,569,854 (F4 notes weighted avg of $67.15–$68.14)
  • 61,822 shares @ $68.27 = $4,220,588 (F5 notes weighted avg of $68.15–$68.45)
• Shares sold in total: 200,000; total proceeds: $13,503,583.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Notable footnotes: F1 — sales were made pursuant to a Rule 10b5‑1 trading plan and these transactions complete that plan. F2–F5 — each reported price is a weighted average of multiple trades within the listed price ranges; SEC can request the per‑trade breakdown.

Context
These trades were executed under a prearranged 10b5‑1 plan, which is commonly used to provide an affirmative defense against insider trading claims and generally indicates the sales were pre-scheduled rather than discretionary. For retail investors: purchases by insiders often attract more attention as potential bullish signals; sales under a 10b5‑1 plan are frequently routine and do not by themselves indicate a change in the insider’s view of the company.